Review





Similar Products

celltrace violet in pbs  (Thermo Fisher)
99
Thermo Fisher celltrace violet in pbs
Celltrace Violet In Pbs, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/celltrace violet in pbs/product/Thermo Fisher
Average 99 stars, based on 1 article reviews
celltrace violet in pbs - by Bioz Stars, 2026-03
99/100 stars
  Buy from Supplier
celltrace violet  (Thermo Fisher)
90
Thermo Fisher celltrace violet
1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by <t>CellTrace</t> Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.
Celltrace Violet, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/celltrace violet/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
celltrace violet - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
celltrace violet ctv  (Thermo Fisher)
90
Thermo Fisher celltrace violet ctv
1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by <t>CellTrace</t> Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.
Celltrace Violet Ctv, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/celltrace violet ctv/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
celltrace violet ctv - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by CellTrace Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.

Journal: ImmunoHorizons

Article Title: Maturation of thymocytes with a monoclonal TCR under control of Trac promoter elements in the absence of β-selection

doi: 10.1093/immhor/vlaf035

Figure Lengend Snippet: 1045 TRex Tcrb −/− CD8 + T cells populate the periphery and are functional. (A) Spleen weights from mice with indicated 1045 and Tcrb genotypes. (B, C) CD8 + T cell frequency of CD45 + splenocytes (B) or number per mg of spleen (C). (D, E) Representative plots (D) of Vβ9 + frequency of CD8 + T cells (E). (F) Vβ9 gMFI on CD8 + T cells. G) CD44 + frequency of Vβ9 + CD8 + T cells. (H–J) Representative plots (H) of γδTCR + CD4 − CD8 − frequency of CD45 + splenocytes (I) or number per mg of spleen (J). (K, L) Representative plots (K) of Vβ9 + and γδTCR + frequency of CD8 + or CD4 + T cells (L). (M) Number of Vβ9 + CD8 T cells from 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes following 72 h of stimulation with varying concentrations of Msln 406–414 peptide. (N) Representative histograms of proliferation of Vβ9 + CD8 + T cells stimulated with 0.1 µg/mL Msln 406–414 peptide as assessed by CellTrace Violet (CTV) dilution. (O) Frequency of Vβ9 + CD8 + T cells by number of divisions in splenocytes stimulated with 0.1 µg/mL Msln 406–414 peptide. (P) Frequency of Vβ9 + CD8 + T cells that reached ≥4 divisions across varying concentrations of Msln 406–414 peptide. (Q) Schematic depicting in vitro priming and restimulation of 1045 +/+ Tcrb + or 1045 +/+ Tcrb −/− splenocytes for evaluation of cytokine production. (R) Representative plots of IFNγ, TNFα, and granzyme B (GzmB) production in Vβ9 + CD8 + T cells following restimulation with 0.001 µg/mL Msln 406–414 peptide. (S–U) IFNγ + (S), IFNγ + TNFα + (T), and GzmB + (U) frequency of Vβ9 + CD8 + T cells following restimulation with varying concentrations of Msln 406–414 peptide. (A–L) Each dot represents an individual animal with n = 3 to 8 animals per group and mean ± SEM shown. (M–U) Mean ± SD of technical triplicates, representative of 3 independent experiments. Comparisons evaluated using 1-way analysis of variance with Tukey posttest in panels A to J and unpaired Student’s t test in panels L to U. * P < 0.05, ** P < 0.005, *** P < 0.001, **** P < 0.0001.

Article Snippet: Cells were then stained with 1 μM CellTrace Violet (Thermo Fisher Scientific) in PBS for 20 min at 37 °C and subsequently quenched with 4 volumes of 4 °C T cell media.

Techniques: Functional Assay, In Vitro